XML 139 R66.htm IDEA: XBRL DOCUMENT v3.22.4

Financial instruments - additional disclosures (Tables)

12 Months Ended

Dec. 31, 2022

Financial Instruments - additional disclosure [abstract]

Disclosure of financial assets and financial liabilities

				2022
(USD millions)		Note		Financial instruments at amortized costs		Financial instruments at fair value through other comprehensive income		Financial instruments at fair value through the consolidated income statement		Other financial liabilities at amortized costs
Cash and cash equivalents		16		7 517
Time deposits and short-term investments with original maturity more than 90 days		16		11 089
Trade receivables		15		8 066
Other receivables and current assets		17		958
Marketable securities - debt securities		16				9
Long-term financial investments - equity securities		13				828		317
Long-term financial investments - debt securities		13				37
Long-term financial investments - fund investments		13						281
Long-term loans, advances, security deposits and other long-term receivables		13		341
Associated companies at fair value through profit and loss								129
Derivative financial instruments		16						204
Contingent consideration receivables		13/17						650
Total financial assets				27 971		874		1 581
Bank and other short-term financial debt		21		863
Commercial paper		21		2 772
Straight bonds		19		22 341
Long-term liabilities to banks and other financial institutions		19		144
Trade payables				5 146
Contingent consideration liabilities (see Note 20/22) and other financial liabilities								1 067
Derivative financial instruments		21						55
Lease liabilities		10								1 789
Total financial liabilities				31 266				1 122		1 789

				2021
(USD millions)		Note		Financial instruments at amortized costs		Financial instruments at fair value through other comprehensive income		Financial instruments at fair value through the consolidated income statement		Other financial liabilities at amortized costs
Cash and cash equivalents 1		16		10 397		2 010
Time deposits and short-term investments with original maturity more than 90 days		16		12 965
Trade receivables		15		8 005
Other receivables and current assets		17		793
Marketable securities - debt securities		16				2 741
Long-term financial investments - equity securities		13				1 195		468
Long-term financial investments - debt securities		13				34
Long-term financial investments - fund investments		13						366
Long-term loans, advances, security deposits and other long-term receivables		13		332
Associated companies at fair value through profit and loss								192
Derivative financial instruments		16						105
Contingent consideration receivables		13						641
Total financial assets				32 492		5 980		1 772
Interest-bearing accounts of employees payable on demand		21		1 814
Bank and other short-term financial debt		21		899
Commercial paper		21		893
Straight bonds		19		25 296
Long-term liabilities to banks and other financial institutions		19		227
Trade payables				5 553
Commitment for repurchase of own shares		18/22		2 809
Contingent consideration liabilities (see Note 20/22) and other financial liabilities								1 094
Derivative financial instruments		21						68
Lease liabilities		10								1 896
Total financial liabilities				37 491				1 162		1 896
1  Includes short-term highly rated government-backed debt securities, with an original maturity of three months or less

Derivative financial instruments

		Contract or underlying principal amount				Positive fair values				Negative fair values
(USD millions)		2022		2021		2022		2021		2022		2021
Forward foreign exchange rate contracts		7 907		13 248		189		92		-41		-35
Commodity purchase contract		97		17		15		13
Options on equity securities		39		82						-14		-33
Total derivative financial instruments included in marketable securities and in current financial debts		8 043		13 347		204		105		-55		-68

Contract or underlying principal amount the derivative financial instruments, by currency

		2022
(USD millions)		EUR		USD		Other		Total
Forward foreign exchange rate contracts		687		5 659		1 561		7 907
Commodity purchase contract		80		17				97
Options on equity securities				39				39
Total derivative financial instruments		767		5 715		1 561		8 043

		2021
(USD millions)		EUR		USD		Other		Total
Forward foreign exchange rate contracts		1 485		5 158		6 605		13 248
Commodity purchase contract				17				17
Options on equity securities				82				82
Total derivative financial instruments		1 485		5 257		6 605		13 347

Fair value by hierarchy

		2022
(USD millions)		Level 1		Level 2		Level 3		Total
Financial assets
Marketable securities
Debt securities				9				9
Derivative financial instruments				204				204
Total marketable securities and derivative financial instruments at fair value				213				213
Current contingent consideration receivables						43		43
Long-term financial investments
Debt and equity securities		473		10		699		1 182
Fund investments		20				261		281
Non-current contingent consideration receivables						607		607
Total long-term financial investments at fair value		493		10		1 567		2 070
Associated companies at fair value through profit and loss						129		129
Financial liabilities
Current contingent consideration liabilities						-131		-131
Derivative financial instruments				-55				-55
Total current financial liabilities at fair values				-55		-131		-186
Non-current contingent consideration liabilities						-704		-704
Other financial liabilities						-232		-232
Total non-current financial liabilities at fair value						-936		-936

		2021
(USD millions)		Level 1		Level 2		Level 3		Total
Financial assets
Cash and cash equivalents
Debt securities 1		2 010						2 010
Total cash and cash equivalents at fair value		2 010						2 010
Marketable securities and derivative financial instruments
Debt securities		2 719		22				2 741
Derivative financial instruments				105				105
Total marketable securities and derivative financial instruments at fair value		2 719		127				2 846
Long-term financial investments
Debt and equity securities		1 080				617		1 697
Fund investments		28				338		366
Contingent consideration receivables						641		641
Total long-term financial investments at fair value		1 108				1 596		2 704
Associated companies at fair value through profit and loss						192		192
Financial liabilities
Contingent consideration payables						-1 075		-1 075
Derivative financial instruments				-68				-68
Other financial liabilities						-19		-19
Total financial liabilities at fair value				-68		-1 094		-1 162
1  Includes short-term highly rated government-backed debt securities, with an original maturity of three months or less

Reconciliation of changes in fair value measurement

		2022
(USD millions)		Associated companies at fair value through profit and loss		Fund investments		Long-term financial investments		Contingent consideration receivables		Contingent consideration liabilities		Other financial liabiltiies
January 1		192		338		617		641		-1 075		-19
Fair value gains and other adjustments, including from divestments recognized in the consolidated income statement				4		35		53		530		15
Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement		-63		-78		-84				-114		-18
Fair value adjustments recognized in the consolidated statement of comprehensive income, including currency translation effects						24				11
Purchases		4		11		160				-231		-238
Cash receipts and payments								-44		44		28
Disposals				-12		-13
Reclassification		-4		-2		-40
December 31		129		261		699		650		-835		-232
Total of fair value gains and losses recognized in the consolidated income statement for assets and liabilities held at December 31, 2022		-63		-74		-49		53		416		-3

		2021
(USD millions)		Associated companies at fair value through profit and loss		Fund investments		Long-term financial investments		Contingent consideration receivables		Contingent consideration payables
January 1		211		366		460		625		-1 046
Fair value gains and other adjustments, including from divestments recognized in the consolidated income statement		2		70		69		124		182
Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement		-26		-8		-13		-44		-189
Fair value adjustments recognized in the consolidated statement of comprehensive income, including currency translation effects		-2		-1		51		-22		22
Purchases		34		12		137				-88
Cash receipts and payments								-42		44
Disposals		-27		-71		-43
Reclassification				-30		-44
December 31		192		338		617		641		-1 075
Total of fair value gains and losses recognized in the consolidated income statement for assets and liabilities held at December 31, 2021		-24		62		56		80		-7

Equity securities measured at fair value through other comprehensive income

(USD millions)		2022		2021
Listed equity securities		438		888
Non-listed equity securities		390		307
Total equity securities		828		1 195

Monitoring of net debt or liquidity based on contractual maturities

		2022
(USD millions)		Due within one month		Due later than one month but less than three months		Due later than three months but less than one year		Due later than one year but less than five years		Due after five years		Total
Current assets
Marketable securities, time deposits and short-term investments with original maturity more than 90 days and accrued interest		4 142		6 911		36				9		11 098
Commodities										111		111
Derivative financial instruments		23		147		19				15		204
Cash and cash equivalents		4 011		3 506								7 517
Total current financial assets		8 176		10 564		55				135		18 930
Non-current liabilities
Financial debt								-8 975		-11 269		-20 244
Financial debt - undiscounted								-9 002		-11 394		-20 396
Total non-current financial debt								-8 975		-11 269		-20 244
Current liabilities
Financial debt		-3 215		-146		-2 515						-5 876
Financial debt - undiscounted		-3 215		-146		-2 517						-5 878
Derivative financial instruments		-38		-13		-4						-55
Total current financial debt		-3 253		-159		-2 519						-5 931
Net debt		4 923		10 405		-2 464		-8 975		-11 134		-7 245

		2021
(USD millions)		Due within one month		Due later than one month but less than three months		Due later than three months but less than one year		Due later than one year but less than five years		Due after five years		Total
Current assets
Marketable securities, time deposits and short-term investments with original maturity more than 90 days and accrued interest		11		14 585		1 088		4		18		15 706
Commodities										111		111
Derivative financial instruments		21		64		7				13		105
Cash and cash equivalents		7 406		5 001								12 407
Total current financial assets		7 438		19 650		1 095		4		142		28 329
Non-current liabilities
Financial debt								-8 464		-14 438		-22 902
Financial debt - undiscounted								-8 490		-14 587		-23 077
Total non-current financial debt								-8 464		-14 438		-22 902
Current liabilities
Financial debt		-2 780		-521		-2 926						-6 227
Financial debt - undiscounted		-2 780		-521		-2 928						-6 229
Derivative financial instruments		-50		-16		-2						-68
Total current financial debt		-2 830		-537		-2 928						-6 295
Net debt		4 608		19 113		-1 833		-8 460		-14 296		-868

Derivative financial instruments and accrued interest on derivative financial instruments

		2022
(USD millions)		Due within one month		Due later than one month but less than three months		Due later than three months but less than one year		Total
Derivative financial instruments and accrued interest on derivative financial instruments
Potential outflows in various currencies - from financial derivative liabilities		-2 029		-4 598		-316		-6 943
Potential inflows in various currencies - from financial derivative assets		2 029		4 712		321		7 062

		2021
(USD millions)		Due within one month		Due later than one month but less than three months		Due later than three months but less than one year		Total
Derivative financial instruments and accrued interest on derivative financial instruments
Potential outflows in various currencies - from financial derivative liabilities		-843		-5 482		-461		-6 786
Potential inflows in various currencies - from financial derivative assets		847		5 516		457		6 820

Other contractual liabilities of the net debt or liquidity

		2022
(USD millions)		Due within three months		Due later than three months but less than one year		Due later than one year but less than five years		Due after five years		Total
Contractual interest on non-current liabilities		-64		-412		-1 432		-3 624		-5 532
Lease liabilities 1		-71		-180		-616		-922		-1 789
Trade payables		-5 020		-126						-5 146
Contingent consideration liabilities		-16		-115		-437		-267		-835
1  Note 10 provides additional disclosures related to lease liabilities.

		2021
(USD millions)		Due within three months		Due later than three months but less than one year		Due later than one year but less than five years		Due after five years		Total
Contractual interest on non-current liabilities		-82		-445		-1 628		-3 908		-6 063
Lease liabilities 1		-78		-197		-639		-982		-1 896
Trade payables		-5 373		-180						-5 553
Commitment for repurchase of own shares		-2 809								-2 809
Contingent consideration liabilities		-54		-65		-517		-439		-1 075
1  Note 10 provides additional disclosures related to lease liabilities.

Potential impact on the consolidated income statement due to increase (decrease) in currency exchange rates

(USD millions)		2022		2021
5% increase in foreign currency exchange rates against USD		-6		3
5% decrease in foreign currency exchange rates against USD		7		-3

Potential impact on the consolidated equity due to increase (decrease) in currency exchange rates

(USD millions)		2022		2021
5% increase in foreign currency exchange rates against USD		93		99
5% decrease in foreign currency exchange rates against USD		-98		-104

Potential impact on the consolidated income statement due to increase (decrease) in equity prices

(USD millions)		2022		2021
15% increase in equity prices		109		154
15% decrease in equity prices		-109		-154

Potential impact on the consolidated equity due to increase (decrease) in equity prices

(USD millions)		2022		2021
15% increase in equity prices		124		179
15% decrease in equity prices		-124		-179

X

- Definition

The disclosure of derivative financial instruments. [Refer: Derivatives [member]]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 1
-IssueDate 2022-03-24
-Paragraph 10
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for fair value measurement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 13
-IssueDate 2022-03-24
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS13_g91-99__IFRS13_g91-99_TI
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfFairValueMeasurementExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: Investments in equity instruments designated at fair value through other comprehensive income]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 7
-IssueDate 2022-03-24
-Paragraph 11A
-Subparagraph c
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_11A_c&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_FinancialInstrumentsAdditionalDisclosureAbstract
Namespace Prefix:	nvs_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_PotentialImpactOnTheConsolidatedIncomeStatementDueToIncreaseDecreaseInCurrencyExchangeRatesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_PotentialImpactOnTheConsolidatedIncomeStatementDueToIncreaseDecreaseInEquityPricesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_PotentialImpactOnTheConsolidatedequityDueToIncreaseDecreaseInCurrencyExchangeRatesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	nvs_PotentialImpactOnTheConsolidatedequityDueToIncreaseDecreaseInEquityPricesTableTextBlock
Namespace Prefix:	nvs_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration